Using the publication of the complete genome sequence of genomics pioneer Craig Venter as a news peg, we explored the coming era of “personalized genomics”, examining the plans of the companies gearing up to provide genome scans, or assessments of “genome health”, to paying customers. We pointed out that even expert medical geneticists have a limited ability to say what this information means for individual health, providing a timely “caveat emptor” warning.
